Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Victoria Nelson is active.

Publication


Featured researches published by Victoria Nelson.


International Archives of Allergy and Immunology | 2017

A Pilot Study Investigating Clinical Responses and Biological Pathways of Azelastine/Fluticasone in Nonallergic Vasomotor Rhinitis before and after Cold Dry Air Provocation

Umesh Singh; Jonathan A. Bernstein; Holly Lorentz; Tara Sadoway; Victoria Nelson; Piyush Patel; Anne Marie Salapatek

Background: Nonallergic vasomotor rhinitis (NAVMR) has been considered a diagnosis by exclusion due to unknown mechanisms or lack of diagnostic biomarkers. Methods: To determine clinical responses and biological pathways in NAVMR subjects challenged to cold dry air (CDA) in an environmental exposure chamber (EEC) pre- and posttreatment with azelastine/fluticasone (AzeFlu), 30 NAVMR subjects, prescreened for CDA-induced symptoms (approx. 14°C, <15% relative humidity, ×1 h) were randomized to treatment with AzeFlu (n = 20) or placebo (n = 10) for 2 weeks. Total nasal symptoms scores, minimum cross-sectional area, cough, and conjunctival redness were recorded at visit 1 (pretreatment) and visit 2 (posttreatment) before, during, and after CDA challenge. At both visits, nasal lavage fluid (NLF) and nasal scrapings (NS) were collected pre- and post-CDA challenge. Substance P, neurokinin-A, and calcitonin gene-related peptide concentrations in NLF were analyzed pre- and postchallenge at each visit. Their relationship with CDA-induced symptoms was determined by statistical analysis. MicroRNA sequencing from NS determined differentially expressed miRNA between the treatment groups post-CDA challenge at each visit. Results: The minimum cross-sectional area (p < 0.05), cough count (p < 0.05), and substance P (p < 0.01) improved posttreatment with AzeFlu versus placebo. Gene targets for differentially expressed miRNAs at visit 1 were enriched for biological pathways regulating epithelial ciliogenesis and cell integrity that were modified in the AzeFlu-treated group versus placebo posttreatment. Conclusions: This study demonstrated the feasibility of an EEC model to investigate CDA-induced clinical responses and pathobiology in NAVMR subjects pre- and posttreatment with AzeFlu. NAVMR disease mechanisms for other nonallergic triggers can be investigated similarly.


The Journal of Allergy and Clinical Immunology | 2018

Correlation between Overall Allergy Symptom Visual Analog Scale (VAS) Scores and Total Symptom Scores (TSS) in Subjects with Ragweed-Induced Allergic Rhinitis in an Environmental Exposure Chamber (EEC)

Anne Marie Salapatek; Cherrie Small; Holly Lorentz; Erin Beattie; Victoria Nelson; Peter Couroux


The Journal of Allergy and Clinical Immunology | 2018

Repeatability of Total Nasal Symptom Scores (TNSS) in Allergic Rhinitis Individuals Using an Electronic Diary during Environmental Exposure Chamber (EEC) Visits

Erin Beattie; Cherrie Small; Holly Lorentz; Victoria Nelson; Peter Couroux; Anne Marie Salapatek


The Journal of Allergy and Clinical Immunology | 2017

Truly Symptomatic Grass-Allergic Subjects Screened with Environmental Exposure Chamber (EEC)

William Zizek; Tara Sadoway; Anne Marie Salapatek; Victoria Nelson


The Journal of Allergy and Clinical Immunology | 2017

Reduction of Re-Aerosolized Household Allergens during Vacuuming with a Product Regime in an Environmental Exposure Chamber (EEC) Model

Tara Sadoway; William Zizek; Anne Marie Salapatek; Victoria Nelson


Investigative Ophthalmology & Visual Science | 2017

Retrospective Analysis of Increment Instillation of Allergen During the Conjunctival Allergen Provocation Test (CAPT)

Holly Lorentz; Victoria Nelson; Nerizsa Tenorio; Anne Marie Salapatek


The Journal of Allergy and Clinical Immunology | 2016

Reduction of Substance-P Mediated Neuronal Hyper-Reactivity By Dymista™ (Azelastine & Fluticasone) Correlates with Decreased Cough-Frequency in Non-Allergic Rhinitis

Umesh Singh; Jonathan A. Bernstein; Holly Lorentz; Tara Sadoway; Victoria Nelson; Piyush Patel; Anne Marie Salapatek


The Journal of Allergy and Clinical Immunology | 2016

Electronic Patient Data Acquisition Tablet (Epdat™) Geofencing Capabilities Allows for Subject Compliance and Pollen Exposure Monitoring Leading to Improved Data Quality in Seasonal Allergy Field Trials

Devang Panchal; D. Wilson; Tara Sadoway; Victoria Nelson; Piyush Patel; Anne Marie Salapatek


The Journal of Allergy and Clinical Immunology | 2016

Field Scores of Allergic Individuals Correlate Positively with Self-Reported Outdoor Exposure Collected Using an Electronic Patient Data Acquisition Tablet (ePDAT™)

Tara Sadoway; Victoria Nelson; Peter Couroux; Anne Marie Salapatek


The Journal of Allergy and Clinical Immunology | 2016

Skin Prick Testing Alone Is Not a Good Predictor of Allergy Symptom Severity in Grass Allergic Patients

Victoria Nelson; Tara Sadoway; Peter Couroux; Anne Marie Salapatek

Collaboration


Dive into the Victoria Nelson's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jonathan A. Bernstein

University of Cincinnati Academic Health Center

View shared research outputs
Top Co-Authors

Avatar

Umesh Singh

University of Cincinnati

View shared research outputs
Researchain Logo
Decentralizing Knowledge